Elicera Therapeutics: Funding, Investors & Team (Sep 2026)
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Elicera Therapeutics has raised $8.2M across 2 funding rounds on record, the most recent an undisclosed round of $150k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Elicera Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Elicera Therapeutics Funding Rounds
Elicera Therapeutics raised $8.0M in an undisclosed round announced in Apr 2026.
1 month later, an undisclosed round of $150k was announced in May 2026.
Elicera Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Elicera Therapeutics Funding Compared to Other Biotechnology Startups
Elicera Therapeutics' latest round of $150k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Elicera Therapeutics in Biotechnology and Göteborg
Companies Similar to Elicera Therapeutics
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D…
Elicera Therapeutics Funding FAQs
What does Elicera Therapeutics do?
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
How much funding has Elicera Therapeutics raised?
Elicera Therapeutics has raised $8.2M across 2 rounds on record. The most recent is an undisclosed round of $150k announced in May 2026.
When did Elicera Therapeutics last raise funding?
Elicera Therapeutics' most recent funding round on record is an undisclosed round of $150k, announced in May 2026.
Who founded Elicera Therapeutics?
FundedIQ lists Jamal El (Founder) at Elicera Therapeutics.
Where is Elicera Therapeutics headquartered?
Elicera Therapeutics is based in Göteborg, Vastra Gotaland, Sweden.
How many employees does Elicera Therapeutics have?
Elicera Therapeutics is in the 1-10 employee band.
How does Elicera Therapeutics' funding compare to other Biotechnology startups?
Elicera Therapeutics' latest round of $150k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Elicera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Elicera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.